Generic applications in Europe to fall as patent abyss recedes
This article was originally published in Scrip
Executive Summary
Generic application filings in Europe are expected to plateau this year, even though the overall number of EMA marketing applications in 2012 is predicated to stay stable. The generics plateau follows a peak of generics filings in 2010 and 2011 as multiple innovator drugs teeter by the patent cliff.